TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / AI Therapeutics Stock

AI Therapeutics Stock

ai-therapeutics.comHealthcareFounded: 2013Funding to Date: $98MM

AI Therapeutics is the developer of a deep learning platform designed to synthesize public and proprietary data on drugs and diseases and finds new indications for our library of new chemical entities.

Buy or sell AI Therapeutics stockLearn more about AI Therapeutics IPO
Register for Details

For more details on financing and valuation for AI Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for AI Therapeutics.

Register Today

Team

Management Team

Henri Lichenstein Ph.D
President, CSO & Chief Executive Officer
Jonathan Rothberg Ph.D
Co-Founder & Board Member
Paul Beckett Ph.D
Senior Director of Drug Discovery
Tian Xu Ph.D
Co-Founder & Scientific Advisor

Board Members

George Rehm JD
Jonathan Rothberg Ph.D
Gregg Fergus
4Catalyzer

Other companies like AI Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Market Screener 01/16/2020
AI Therapeutics : Announces that a Common LAM-002 Mechanism in Cancer and Neurodegenerative Diseases Shows Antitumor Activity in the Clinic and Hope for ALS
FinSMEs 03/31/2017
LAM Therapeutics Raises $58M in Series C Funding |FinSMEs
LAM Therapeutics, a Guilford, Conn.-based developer of drugs for cancer and rare diseases, closed $58M in Series C financing. The backers were not disclosed. The company intends to use the funds to advance its drugs. Led by Henri Lichenstein, Ph.D., and Dr. Tian Xu, LAM Therapeutics develops precision therapeutics and companion diagnostics for cancer and …

Trending Companies

Frequently Asked Questions